Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 10/2016

01-10-2016 | Erratum

Erratum to: Bone density in proton pump inhibitors users: a prospective study

Authors: Kamil Ozdil, Resul Kahraman, Abdurrahman Sahin, Turan Calhan, Erdem H. Gozden, Umit Akyuz, Burak Erer, Mehmet H. Sokmen

Published in: Rheumatology International | Issue 10/2016

Login to get access

Excerpt

The authors noticed a discrepancy between the text and table in terms of patient number according to the gender in the published article. The patient numbers in Table 1 and statistics were true. However, the patient numbers in the second sentence of the ‘Results’ section were incorrect. The correct sentence should read as follows: …
Metadata
Title
Erratum to: Bone density in proton pump inhibitors users: a prospective study
Authors
Kamil Ozdil
Resul Kahraman
Abdurrahman Sahin
Turan Calhan
Erdem H. Gozden
Umit Akyuz
Burak Erer
Mehmet H. Sokmen
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 10/2016
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3554-8

Other articles of this Issue 10/2016

Rheumatology International 10/2016 Go to the issue

Food for Thought

Symptoms of Raynaud’s phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology

Epidemiology of RMD

Kawasaki disease incidence at Chandigarh, North India, during 2009–2014

Validation Studies

Evidence for reliability, validity and responsiveness of Turkish Foot and Ankle Ability Measure (FAAM)

Validation Studies

Chinese adaptation and validation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) in patients with knee osteoarthritis

Food for Thought

Fatigue, pain and patient global assessment responses to biological treatment are unpredictable, and poorly inter-connected in individual rheumatoid arthritis patients followed in the daily clinic

Pathology Review

Spinal fractures in patients with ankylosing spondylitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits